Le Lézard
Classified in: Health
Subjects: NPT, SVY, AVO

New Report: Organ Transplant Abuse in China Continues Despite Claims of Reform


NEW YORK, July 16, 2018 /PRNewswire-USNewswire/ -- Severe abuses continue in China's organ transplant system?including the sourcing of organs from prisoners of conscience on a large scale?despite Chinese government assertions of reform, finds a new study by the China Organ Harvest Research Center.

The report was released at the 27th International Congress of The Transplantation Society, a biennial gathering of transplant experts from around the world.

"Chinese officials asserted that the donation framework was developed in just a few years, a process that took other countries decades," the authors note. "Official accounts indicate that the percentage of organs sourced from donations jumped from 23% in 2013 to 80% in 2014, with voluntary donations becoming the sole official organ source in 2015. It is not plausible that such a complete transition in this system could have taken place in just one or two years."

The report concludes that this disparity, together with other factors?including evidence of on-demand transplants and data falsification?means that many organs must be coming from elsewhere, including prisoners of conscience.

In preparing the 341-page report, researchers analyzed hundreds of transplant hospitals, government and industry statements, official policies and legislation, actual donation figures from various regions, the abuse of brain death criteria, and the broader operation of China's donation and transplant system.

"The report highlights new evidence that has come to light since a June 2016 study by human rights lawyer David Matas, former Canadian Secretary of State for Asia-Pacific and Member of Parliament David Kilgour, and investigative journalist Ethan Gutmann," says Dr. Huige Li, Professor at the University Medical Center of Mainz and co-author of the report.

The new report's key findings include:

"China, as this outstanding, thorough and well-documented report shows, continues to permit abuses of human rights and the minimal ethical treatment of its citizens in permitting killing in order to obtain organs for transplant," writes Professor Arthur L. Caplan, head of the division of medical ethics at New York University's School of Medicine, in a preface to the report. "The report must be attended to by both the transplant community and governments all over the world."

The report concludes that China's purported reform has gained recognition by some international transplant organizations as a result of public relations campaigns, use of questionable data, aggressive roadmaps, transplant center showcases, and presentations at international forums.

"Our findings underscore the problem with taking the Chinese government's claims of reform at face value. We hope it leads to a re-evaluation of how international institutions engage with Chinese transplant entities," says Grace Yin, author and lead researcher of the study.

Given that China's transplant system continues to be supported by the killing of innocents, the authors warn, "By expanding agreements to share organs with other parts of Asia, Belt and Road regions, and beyond, the Chinese regime also risks implicating the international community in its crimes."

The full report is available at: https://www.chinaorganharvest.org/app/uploads/2018/06/COHRC-2018-Report.pdf

The China Organ Harvest Research Center (COHRC) is a nonprofit organization that conducts and presents authoritative research on organ transplant abuse in China. Its researchers seek out and analyze evidence from a wide range of Chinese and overseas sources. Before establishing this organization in 2017, its lead researchers had studied the Chinese organ transplantation system for over a decade and contributed to reports cited by CNN, The New York Times, PBS, The Globe and Mail, and The Times of London.

Contact:
David Li
+17134102705
[email protected]

New Report: Organ Transplant Abuse in China Continues Despite Claims of Reform

Co-author David Li introduces the latest developments in China's organ transplant and donation system at the report's release in Madrid, Spain.

SOURCE China Organ Harvest Research Center


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: